Abstract:There has been increased interest in the use of polymeric nanoparticles as carriers for near-infrared fluorescence (NIRF) dyes for cancer diagnosis. However, efficient delivery of nanoparticles to the tumors after systemic administration is limited by various biobarriers. In this study, we investigated the pharmacokinetics, biodistribution, and tumor uptake of sub-nanometer sized polymeric nanoparticles (<100 nm in diameter) coated with polyethylene glycol in tumor-bearing mice. To facilitate our studies, these particles were labeled with gamma emitter indium-111. We found that two NIRF nanoparticles having the same size (approximately 20 nm) and chemical composition but different structures (i.e., hydrogel versus core-shell nanolatex), or the same core-shell nanolatex particles with different sizes (20, 30, and 60 nm), had different blood circulation times, biodistribution, and tumor uptake. Interestingly, the tumor uptake of the nanolatex particles correlated well with their blood residence times (R(2) = 0.95), but similar correlations were not found between nanogel and nanolatex particles (R(2) = 0.05). These results suggest that both the blood circulation time and the extent of hydration of the nanoparticles play an important role in the tumor uptake of nanoparticles. Prolonged blood circulation of these NIRF nanoparticles allowed clear visualization of tumors with gamma-scintigraphy and optical imaging after intravenous administration. A better understanding with regard to how the characteristics of nanoparticles influence their in vivo behavior is an important step towards designing NIRF nanoparticles suitable for molecular imaging applications and for efficient tumor delivery.

Effect Of Injection Routes On The Biodistribution, Clearance, And Tumor Uptake Of Carbon Dots

Carbon Dots of Different Composition and Surface Functionalization: Cytotoxicity Issues Relevant to Fluorescence Cell Imaging

Pharmacokinetic Issues of Imaging with Nanoparticles: Focusing on Carbon Nanotubes and Quantum Dots

Biodistribution study of carbogenic dots in cells and in vivo for optical imaging

Tumor-Targeted Fluorescence Imaging and Mechanisms of Tumor Cell-Derived Carbon Nanodots

In vivo toxicology of carbon dots by 1H NMR-based metabolomics.

Carbon quantum dots in breast cancer modulate cellular migration via cytoskeletal and nuclear structure

Pharmacokinetics and Biodistribution of Near-Infrared Fluorescence Polymeric Nanoparticles

Photoluminescent Carbon Dots As Biocompatible Nanoprobes for Targeting Cancer Cells in Vitro

In Vivo Theranostics with Near-Infrared-emitting Carbon Dots—highly Efficient Photothermal Therapy Based on Passive Targeting after Intravenous Administration

Advances in the application of biosynthesized carbon dots as fluorescent probes for bioimaging

Preparation of Fluorescent Carbon Dots Composites and Their Potential Applications in Biomedicine and Drug Delivery—A Review

Image-guided selection of Gd@C-dots as sensitizers to improve radiotherapy of non-small cell lung cancer

Biodistribution and Toxicity Assessment of Intratumorally Injected Arginine-Glycine-aspartic Acid Peptide Conjugated to CdSe/ZnS Quantum Dots in Mice Bearing Pancreatic Neoplasm

Preparation and Biological Evaluation of Photoluminescent Carbonaceous Nanospheres

Advances in Biodistribution Study and Tracing Methodology of Carbon Nanotubes.

Impact of administration route on nanocarrier biodistribution in a murine colitis model

Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer

Preparation and Biodistribution of Tyrosine Modified Multiwall Carbon Nanotubes

In Vivo Behavior of Near Infrared-Emitting Quantum Dots.

Carbon Dots: Applications in Bioimaging and Theranostics